Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPADE study of dexmedetomidine for pain after spinal fusion surgery
ACTRN12621000557831Phase 4Recruiting
- Sponsor
- Royal Melbourne Hospital
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in postoperative pain, sponsored by Royal Melbourne Hospital. Primary endpoint: Pain intensity by Numerical Rating Scale. Started May 2021; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12621000557831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000557831.